H-ALFDIESKV-OH

Ref. 3D-PP45483

Informations sur le produit

• Nom: H-ALFDIESKV-OH
• Synonymes: NH2-Ala-Leu-Phe-Asp-Ile-Glu-Ser-Lys-Val-OH

Description

Peptide H-ALFDIESKV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ALFDIESKV-OH include the following: Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4. 1 and LGIII-220.6. 2 X Wang, B Liang, V Rebmann , J Lu, E Celis - Tissue , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-0039.2003.00087.x Clinical trials of cancer therapies targeting prostate-specific membrane antigen WC Olson, WDW Heston - Reviews on recent , 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/rrct/2007/00000002/00000003/art00004 Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation S Garetto, F Sizzano, D Brusa, A Tizzani, F Malavasi - , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/14653240903164971 Activated integrins identify functional antigen-specific CD8+ T cells within minutes after antigen stimulation S Dimitrov , C Gouttefangeas - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1720714115 PRECLINICAL STUDIES WITH AN IRX-2 ENHANCED PROSTATE VACCINE PH Naylor , HJ Brandwein, CW Naylor - The Journal of , 2008 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2808%2960135-4 Genistein mediated histone acetylation and demethylation activate tumor suppressor genes in prostate cancer N Kikuno, H Shiina, S Urakami, K Kawamoto - The Journal of , 2008 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2808%2960136-6 Dendritic cell-based immunotherapy of prostate cancer ML Salgaller, BA Tjoa, PA Lodge - Critical Reviews™in , 1998 - dl.begellhouse.comhttps://www.dl.begellhouse.com/journals/2ff21abf44b19838,4214e868375e8210,7c95323b36d5d8a8.html Anterior perirectal fat tissue diminishes the focusing energy by transrectal high-intensity focused ultrasound (HIFU) and strongly influences the outcome of prostate M Sumitomo, M Tobe, K Ito, A Horiguchi - The Journal of , 2008 - auajournals.orghttps://www.auajournals.org/doi/pdf/10.1016/S0022-5347%2808%2960137-8 The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer L Matera - Cancer treatment reviews, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737209001637 Synthesis of Lipoprotein Immunostimulants for Treating Prostate Cancer JC Hinshaw, UTAH UNIV SALT LAKE CITY - 2004 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/ADA423265 Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen J Lu, E Celis - Cancer research, 2002 - AACRhttps://aacrjournals.org/cancerres/article-abstract/62/20/5807/509292 Adenoviral transgene ubiquitination enhances mouse immunization and class I presentation by human dendritic cells H Rouard, B Klonjkowski, J Marquet, C Lahet - Human gene , 2003 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/104303403322319408 Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients GP Murphy, P Snow, SJ Simmons, BA Tjoa - The , 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0045(20000101)42:1%3C67::AID-PROS8%3E3.0.CO;2-I Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides BA Tjoa, SJ Erickson, VA Bowes, H Ragde - The , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0045(19970901)32:4%3C272::AID-PROS7%3E3.0.CO;2-L

• Marque: Biosynth